Micevic G, Muthusamy V, Damsky W, Theodosakis N, Liu X, Meeth K et al
The theory is that smaller, more frequent doses produce a smoother pharmacokinetic profile with less dramatic peaks in GLP-1 activity, potentially reducing the intensity of gastric emptying delay and associated reflux
and G.M.D., R21OD026444 to E.E.S
Food and Drug Administration (FDA) conducted an internal review on the safety of GLP-1s that analyzed clinical reports of suicidal thoughts associated with using those medications
However, the initially hypothesized mechanism was incorrect, as it was later discovered that the hormone achieved its effects only when its concentration exceeded basal physiologic levels and that it operated similarly to secretin
Surgical protocol To induce ischemic AKI 17 , mice were anesthetized with intraperitoneal avertin (2,2,2-tribromoethanol